For: | Doherty S, Mulholland M, Shields M, McCrossan P. Can omalizumab be used effectively to treat severe conjunctivitis in children with asthma? A case example and review of the literature . World J Clin Pediatr 2021; 10(4): 48-52 [PMID: 34316438 DOI: 10.5409/wjcp.v10.i4.48] |
---|---|
URL: | https://www.wjgnet.com/2219-2808/full/v10/i4/48.htm |
Number | Citing Articles |
1 |
O. E. Semernik, A. A. Lebedenko, E. B. Tyurina, V. S. Rudiakova, N. A. Gevorkian, M. A. Kristosturian. Biological therapy of severe bronchial asthma in a child. Meditsinskiy sovet = Medical Council 2024; (1): 312 doi: 10.21518/ms2024-003
|
2 |
Serge Doan, Nikolaos G. Papadopoulos, Jason K. Lee, Salvatore Leonardi, Sara Manti, Susanne Lau, Carmen Rondon, Vibha Sharma, Uwe Pleyer, Xavier Jaumont, Slawomir B. Lazarewicz. Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab. World Allergy Organization Journal 2023; 16(6): 100788 doi: 10.1016/j.waojou.2023.100788
|